Personalized Tobacco Treatment in Primary Care (MOTIVATE)
A Multilevel Intervention to Personalize and Improve Tobacco Treatment in Primary Care (MOTIVATE)
Washington University School of Medicine
850 participants
Sep 29, 2023
INTERVENTIONAL
Conditions
Summary
This study examines the application of precision treatment intervention for smoking cessation from both the clinician perspective and patient perspective, and compares it to usual care on tobacco treatment in the primary care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This approach may increase effectiveness and adherence for the patient, and increase the clinician's likelihood of prescribing.
Eligibility
Inclusion Criteria10
- Eligibility Criteria for Primary and Specialty Care Clinicians
- Clinician from participating clinic
- At least 18 years of age
- Can speak and understand English
- Eligibility Criteria for Primary Care and Specialty Patients
- Patient at participating clinic
- Age 18 years or older, inclusive
- Current smoking (cigarettes per day \>=5)
- Can speak and understand English
- Willing to consider medication to help reduce craving or smoking such as nicotine patch, lozenge, or varenicline
Exclusion Criteria3
- Active use of smoking cessation medication (within the past 30 days)
- Receipt of smoking cessation medication or prescription for smoking cessation medication (within the past 30 days)
- Having a contraindication for cNRT or varenicline (allergic reactions, current cardiac problems, pregnancy)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Precision treatment will be informed by practice guidelines (standard of care, brief advice, and guideline awareness), plus patient-specific risk feedback and personalized tobacco treatment recommendations using patients' clinical, genetic, and biomarker information.
Usual care will be informed by practice guidelines (standard of care, brief advice, and guideline awareness).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05846841